嗜肺巴氏杆菌在实验大鼠和小鼠中的传染性研究

目的观察不同来源的嗜肺巴氏杆菌在实验大鼠和小鼠中的传染性.方法取源于野鼠、实验大鼠和小鼠的嗜肺巴氏杆菌3株,对30只受试大鼠和小鼠进行交叉人工感染,并于感染后不同时期取咽拭子分离培养,对感染前后菌株,应用RAPD-PCR、SDS-PAGE和Western blot进行基因型、蛋白和抗原成份比较,以及生物学特性的比较.结果受试实验动物对3株嗜肺巴氏杆菌均易感,被接种的动物能稳定携带嗜肺巴氏杆菌直到试验结束,重新分离的嗜肺巴氏杆菌在生物学特性、蛋白成份、抗原性和基因型方面无明显改变.结论同一株嗜肺巴氏杆菌能在实验大鼠和小鼠中相互传染.     

嗜肺巴氏杆菌外膜蛋白和脂多糖抗原在血清学诊断中的意义

目的评价嗜肺巴氏杆菌外膜蛋白(OMP)和脂多糖(LPs)作为血清学诊断抗原的敏感性和特异性.方法用OMP、LPS和全菌(WC)作为Western blot和ELISA的诊断抗原检测自然感染和实验感染嗜肺巴氏杆菌小鼠相应的IgG抗体滴度,同时测定3种抗原与实验动物常见致病菌的交叉反应.结果与嗜肺巴氏杆菌自然感染和实验感染小鼠血清的ELISA反应中,不同时期,LPS作为诊断抗原时血清抗体阳性率最高,WC次之,OMP最低.自然感染小鼠群中,出生4周LPS抗体阳性率即可达80%,而同期的WC和OMP仅为25%和20%,故LPS敏感性最高.与实验动物常见致病菌免疫血清和阴性种鼠血清的ELISA反应中,WC抗原表现出较高的吸光度(A)值,经Western blot证实,其反应为非特异性反应,LPS抗原特异性最强,OMP抗原次之.结论混合多株具有型或种特异性的OMP或LPS作为ELISA的诊断抗原,无论从特异性和敏感性上均高于全菌抗原.     

牛巴氏杆菌病多重PCR检测技术的建立与应用

【背景】牛巴氏杆菌病是由血清型(A、B、E)多杀性巴氏杆菌(Pasteurella multocida,Pm)引起的一种严重危害养牛业的重要传染病,病原学聚合酶链反应(polymerase chain reaction,PCR)方法是诊断并防控该病的有效手段。【目的】建立检测血清型(A、B、E)多杀性巴氏杆菌的多重PCR方法,为临床诊断牛巴氏杆菌病和病原分型提供技术支撑。【方法】参考多杀性巴氏杆菌hyaD-hyaC基因、bcbD基因和ecbJ基因特异区域,设计3对特异性引物,以温度梯度PCR法确定适宜退火温度(T_m);采用棋盘试验优化引物浓度并初步建立多重PCR方法;采用重组质粒标准品及阳性菌株菌液确定其敏感性(最小检测量);以8种常见牛感染病原体[溶血性曼氏杆菌(Mannheimia hemolytica)C1655、大肠埃希氏菌(Escherichia coli)C237、产单核细胞李氏杆菌(Listeria monocytogenes)C1597、金黄色葡萄球菌(Staphylococcus aureus)C3053、都柏林沙门氏菌(Salmonella dublin)C79351、副结核分枝杆菌(Mycobacterium paratuberculosis)C1625、牛传染性鼻气管炎病毒(bovine infectious rhinotracheitis virus)CAV1546和牛支原体分离株(Mycoplasma bovis)C65-1]核酸样本确定其特异性;制备3批诊断试剂,对敏感性和特异性样品进行批间和批内试验,确定其重复性;运用建立的方法使用3种不同型号的PCR仪检测敏感性和特异性样品,确定其适用性;通过检测临床样本及人工模拟感染样本评价临床应用效果。【结果】在T_m为55℃时,3对引物浓度分别为0.25、0.30和0.20μmol/L条件下建立多重PCR方法较优,可以同时检测多杀性巴氏杆菌血清A型(821bp)、血清B型(203bp)和血清E型(363bp);该方法敏感性高,对重组质粒标准品pMD-A、pMD-B和pMD-E检测限分别为43.080、3.710和4.350copies/μL,对阳性菌液最低检出限均为10²CFU细菌;其特异性强,仅对血清型(A、B、E)多杀性巴氏杆菌有特异性扩增条带,同时对其他病原体均无扩增条带;该方法重复性良好,批间与批内试验均一致;临床样本及人工模拟感染样本检测结果显示与病原分离鉴定符合率为100%。【结论】成功建立了一种可鉴定不同血清型的牛多杀性巴氏杆菌多重PCR检测方法。     

灭活巴氏杆菌苗菌对无特殊病原体(SPF)家兔的保护作用

<正>抗多杀巴氏杆菌(Pasteurella multocida)感染的预防接种效果,采用引起诸如窦炎、鼻炎、肺炎及败血症等不同表现的多杀巴氏杆菌株感染家兔可作实地研究。作者早期工作表明,家兔分离的不同多杀巴氏杆菌株,对小鼠和家兔的毒性差异很大。本文报     

多杀性巴氏杆菌抗原的研究进展

多杀性巴氏杆菌在自然界分布广泛,是畜、禽、野生动物及人类的一种共患性病原,可以在同种和不同种的动物间传播,并引起多种畜禽巴氏杆菌病,本文就多杀性巴氏杆菌的抗原成分进行概述。     

多杀性巴氏杆菌攻毒小鼠肺脏的转录组分析

多杀性巴氏杆菌(Pasteurella multocida)可感染多种动物宿主并引发败血症和呼吸道疾病,危害动物健康,给养殖业带来严重经济损失。本研究为探究多杀性巴氏杆菌感染期间对宿主肺脏基因表达的影响,选取羊源A型多杀性巴氏杆菌对小鼠(Mus musculus)进行攻毒实验,攻毒后72 h采集小鼠肺脏组织并提取总RNA。基于转录组测序,与对照组相比,攻毒组获得2 443个差异表达基因,其中有1 437个基因上调,1 006个基因下调。对2 443个差异表达基因进行GO富集分析,结果显示,差异基因显著富集的GO terms主要有B细胞稳态、T细胞迁移的正调控、整合素复合物和胶原蛋白结合;KEGG富集分析结果显示,差异基因显著富集于11条免疫炎症信号通路,包括细胞因子与细胞因子受体互作、趋化因子信号通路等;免疫炎症相关信号通路中,差异基因经蛋白质-蛋白质互作分析,结果显示,C3、C3ar1、C5ar1、Cxcl10、Cxcr2和Gng11基因处于网络中心,说明这些基因在多杀性巴氏杆菌感染过程中发挥了重要作用;从11条免疫炎症通路的基因中挑选10个进行实时荧光定量PCR验证,发现有8个基因...     

巴氏杆菌糖酵解酶的黏附作用研究

巴氏杆菌（主要是多杀性巴氏杆菌）可以引起多种动物疫病（巴氏杆菌病）,同时也引起人类感染发病。[目的] 研究巴氏杆菌糖酵解酶对宿主细胞（兔肾细胞）和两种常见分子[纤连蛋白（fibronectin,Fn）和血浆纤维蛋白溶解酶原（plasminogen,Plg）]的黏附作用。[方法] 采用原核表达系统对多杀性巴氏杆菌的糖酵解酶进行表达并纯化及制备多克隆抗体,通过菌体表面蛋白定位检测、黏附与黏附抑制等实验探究巴氏杆菌糖酵解酶的黏附作用。[结果] 菌体表面蛋白检测结果显示除烯醇化酶和丙酮酸激酶外的7个糖酵解酶在多杀性巴氏杆菌表面存在。这7个糖酵解酶均能黏附兔肾细胞,但仅有磷酸葡萄糖异构酶的多克隆抗体能对多杀性巴氏杆菌黏附宿主细胞产生抑制作用。Far Western blotting结果显示9个糖酵解酶均能结合宿主Fn和Plg。招募抑制实验结果显示磷酸葡萄糖异构酶、醛缩酶、磷酸甘油酸变位酶的抗体对多杀性巴氏杆菌结合Fn和Plg都有抑制作用,磷酸果糖激酶、丙糖磷酸异构酶、甘油醛-3-磷酸脱氢酶、磷酸甘油激酶抗体仅对多杀性巴氏杆菌结合Fn或Plg有抑制作用。[结论] 多杀性巴氏杆菌糖酵解酶成员葡萄糖异构酶、磷酸果糖激酶、醛缩酶、丙糖磷酸异构酶、甘油醛-3-磷酸脱氢酶、磷酸甘油激酶、磷酸甘油酸变位酶在多杀性巴氏杆菌黏附宿主细胞或分子过程中发挥作用。该研究的完成将加深巴氏杆菌病分子发病机制的认识,并为巴氏杆菌病的诊断标识筛选、新型疫苗创制和药物靶标筛选等提供基础数据。     

野猪瘁死症病原的分离鉴定

采集病死野猪的脾脏和血清,用特异抗猪瘟病毒抗体进行琼脂扩散试验检测发现有明显的沉淀线出现,证明野猪感染了猪瘟病毒,猪的致病性实验表明并非猪瘟强毒感染。采集病死野猪的心、肝、脾、肺、心血,经镜检、细菌分离培养、纯培养、生化试验和细菌G C mol%含量测定等检验,证实致病细菌有多杀巴氏杆菌,其G C mol%含量为39.7。毒力测试发现巴氏杆菌具有较强的致病性,LD50=10-1.57/0.5 ml。化脓放线杆菌的分离和毒力表明,化脓放线杆菌也参与致病作用。由此推测本次致死野猪的病原体为多杀巴氏杆菌并发或继发猪瘟病毒、化脓放线杆菌的三重感染所致。纸片扩散法(K-B法)药敏试验表明,两株细菌对头孢哌酮、头孢唑啉、丁胺卡拉霉素等高度敏感,为临床治疗和有效预防该瘁死症奠定基础。     

嗜肺巴氏杆菌蛋白及抗原图谱初步分析

对不同来源的 1 1株嗜肺巴氏杆菌进行了全菌可溶性蛋白及抗原图谱分析。使用SDS -聚丙烯酰胺凝胶电泳 (SDS -PAGE) ,梯度凝胶电泳结果显示 ,嗜肺巴氏杆菌蛋白主要分布于相对分子质量 ( 1 4 4～ 97 4)× 1 0 3,且带型基本一致。 6株菌与参考菌株有完全相同的蛋白带 ,另外 5株则缺乏 40× 1 0 3带。分别用嗜肺巴氏杆菌免疫血清和自然感染嗜肺巴氏杆菌小鼠血清对 1 1株菌进行了免疫印迹 (Westernblots)试验。与免疫小鼠血清的反应显示 ,1 1株受试菌主要有相对分子质量大约 ( 1 7、31 )× 1 0 3两条反应带 ;在与自然感染血清的反应中主要的反应带在 1 7× 1 0 3处 ,缺乏 40× 1 0 3蛋白的 5株菌有 31× 1 0 3反应带 ,其余 7株均有大约 ( 2 0、2 8)× 1 0 3的反应带 ,故可以认为该菌主要抗原大约为 ( 1 7、31 )× 1 0 3;1 0个流行株根据 40× 1 0 3蛋白和 ( 2 0、2 8)× 1 0 3抗原的有无可被分为两型。本研究为精制血清学方法的诊断抗原 ,以及将SDS -PAGE和Westernblot法用于嗜肺巴氏杆菌检测奠定了基础。     

不同牛分枝杆菌特异性基因PCR方法的比较

【背景】牛结核病是我国二类动物疫病,世界动物卫生组织将其列为法定报告的动物疫病。牛主要通过患病牛呼吸道分泌物和咳嗽所产生的气溶胶感染;人则主要通过食用未经高温处理的病牛的肉或奶感染。因此,经过病原学PCR检测对疑似患病牛牛奶或屠宰组织样品进行快速检验确诊,能够最大限度地减少奶牛养殖中乳品生产业的经济损失。【目的】研究并确定适宜的牛分枝杆菌PCR扩增引物及参数,为临床快速准确诊断牛结核病提供参考。【方法】对已报道的5对PCR引物,运用降落(touch down) PCR法确定适宜退火温度(Tm);运用梯度稀释的牛分枝杆菌C68001株(国内牛结核菌素生产用菌株)基因组DNA以及不同菌液含量的人工模拟临床样本(淋巴结、肺脏和牛奶),确定不同引物PCR方法的敏感性;同时以6种常见牛感染菌(牛种布鲁氏菌2308、羊种布鲁氏菌Rev.1、牛分枝杆菌C68001和AN5、禽分枝杆菌C68202、副结核分枝杆菌C68681和胞内分枝杆菌C68226)核酸样本,确定不同引物PCR方法的特异性。【结果】所有引物在53-63℃均含有目的条带,确定引物的最佳退火温度是60℃。在细菌核酸敏感性检验中,1号和3...     

Herpes simplex virus type 1 gene UL14: phenotype of a null mutant and identification of the encoded protein

Herpes simplex virus type 1 (HSV-1) gene UL14 is located between divergently transcribed genes UL13 and UL15 and overlaps the promoters for both of these genes. UL14 also exhibits a substantial overlap of its coding region with that of UL13. It is one of the few HSV-1 genes for which a phenotype and protein product have not been described. Using mass spectrometric and immunological approaches, we demonstrated that the UL14 protein is a minor component of the virion tegument of 32 kDa which is expressed late in infection. In infected cells, the UL14 protein was detected in the nucleus at discrete sites within electron-dense nuclear bodies and in the cytoplasm initially in a diffuse distribution and then at discrete sites. Some of the UL14 protein was phosphorylated. A mutant with a 4-bp deletion in the central region of UL14 failed to produce the UL14 protein and generated small plaques. The mutant exhibited an extended growth cycle at low multiplicity of infection and appeared to be compromised in efficient transit of virus particles from the infected cell. In mice injected intracranially, the 50% lethal dose of the mutant was reduced more than 30,000-fold. Recovery of the mutant from the latently infected sacral ganglia of mice injected peripherally was significantly less than that of wild-type virus, suggesting a marked defect in the establishment of, or reactivation from, latent infection.     

Delayed treatment with doxycycline has limited effect on anthrax infection in BLK57/B6 mice

Blk57/B6 mice were infected with LD90 dose of Sterne strain anthrax spores subcutaneously and then treated with doxycycline. Doxycycline at a dose of 1.5mg/kg, by intra-peritoneal injection, protected mice from death when given at the same time as spores. When doxycycline administration was delayed 4h survival is 90%. Delay of 24h increased survival time but had no impact on eventual mortality. When doxycycline was delayed 48h, mortality and time to death were comparable to sham injection. Peritoneal macrophages harvested from Blk57/B6 mice were examined for response to anthrax lethal toxin and are shown to be deficient in their ability to produce TNF-alpha and have increased expression of IL-6 compared to RAW 264.7 murine macrophage cell line. These findings suggest that antibiotic therapy has limited effects following lethal anthrax spore challenge, even when the host is of a phenotype that does not produce TNF-alpha in response to anthrax lethal toxin exposure.     

Type I IL-1 receptor blockade exacerbates murine listeriosis.

It was found that IL-1 is produced in livers and spleens of mice shortly after the i.v. injection of a sublethal or lethal Listeria monocytogenes inoculum. In sublethally infected mice, IL-1 was present in infected livers and spleens by the end of the first day of infection. Thereafter, the amounts of IL-1 in these organs increased and decreased in concordance with bacterial numbers. IL-1 was not present in the peripheral circulation of mice during sublethal listeriosis, but was present in the blood late in lethal infection. Evidence showing that IL-1 plays a role in antibacterial resistance early in listeriosis was obtained through the use of 35F5 mAb that binds to the murine type I IL-1R and functions to block IL-1 alpha and IL-1 beta actions. Blockade of the type I IL-1R by the 35F5 mAb results in greatly enhanced bacterial growth in the livers and spleens of mice that had received a sublethal Listeria inoculum. Consistent with the exacerbation of listeriosis caused by 35F5 mAb, but in contrast to the effect of 35F5 mAb in other murine models, 35F5 mAb-treated mice exhibit markedly elevated levels of IL-6 in their circulation and infected organs.     

Detection of guinea pig macrophages by a new CD68 monoclonal antibody, PM-1K

A new monoclonal antibody, PM-1K, was raised against 24-h cultured human peritoneal macrophages. In immunohistochemical assays, PM-1K recognized freshly isolated blood monocytes and most tissue macrophages as well as myeloid dendritic cells such as Langerhans cells and interdigitating cells. The molecular size of the antigen recognized by PM-1K was determined to be 110 kD by means of immunoaffinity purification. Because this affinity-purified antigen recognized by PM-1K was also recognized by anti-CD68 antibodies, it is believed to be one of the heterogeneous molecules of the CD68 antigen. Analysis showed interspecies reactivity of PM-1K with macrophages from guinea pigs, pigs, bovine species, and monkeys. Among these macrophages, those of the guinea pig reacted strongly with PM-1K. Patterns of PM-1K immunostaining in guinea pig tissues were similar to those found in human tissues. Studies with the immunoelectron microscope revealed reaction products of PM-1K in the cytoplasm, especially around endosomes. Since only a few antibodies are available to label guinea pig macrophages, PM-1K is considered to be one of the most suitable antibodies to examine macrophages in experimental guinea pig models.     

Antiviral effects of double-stranded RNA from rice dwarf virus on infection of mice with western equine encephalitis virus.

A single administration (1 to 10 mg/kg) of rice dwarf virus RNA (RDV-RNA) prior to virus challenge reduced the mortality of mice infected with western equine encephalitis (WEE) virus. The protective effect of RDV-RNA was significantly higher than that of polyinosinic-polycytidylic acid. However, when these RNAs were given after virus infection, the protective effect was negligible. The titer of circulating interferon in mice reached a peak about 5 hr after injection of these RNAs and remained at this level for about 24 hr. Viremia in mice infected with a lethal dose of WEE virus was markedly suppressed by the treatment of mice with these RNAs. A pathological examination of mice treated with a lethal dose of RDV-RNA revealed marked changes including degeneration and karyorrhexis in the lymphoid tissues of the spleen.     

Lack of correlation between cytotoxic T lymphocytes and lethal murine lymphocytic choriomeningitis

Adoptive transfer of lymph node and spleen cells from mice infected with LCM virus to similarly infected immunocompromised recipients has been the classic way to demonstrate the lethal role of T cells in the CNS disease caused by this virus. Isolation and adoptive transfer techniques are presented here which show that Thy-1+ cells isolated from the meningeal infiltrates (MI) of LCM virus-infected mice possess this property. We compared various T cell functions of MI cells taken from mice infected with two strains of LCM virus differing markedly in their pathogenicities. One of these strains, termed aggressive, caused a typical, invariably fatal, CNS disease within 7 to 10 days after infection. The other virus, termed docile, killed few mice after the standard intracerebral inoculation, and could persist in the mice for 6 mo or more. The yields of MI leukocytes from mice infected with docile virus varied from 50 to 100% of those found in mice infected with aggressive virus (3 X 10(6) cells/brain). On a cell-to-cell basis, the CTL activity in the MI of mice infected with docile virus ranged from 50 to 100% of that found in the MI of mice infected with aggressive virus. MI cells from mice infected with aggressive virus consistently caused lethal disease by adoptive transfer into immunocompromised (irradiated) recipients infected with either strain of virus. All attempts to induce lethal disease by adoptive transfer of MI cells (or splenocytes) from mice infected with docile virus into irradiated recipients failed. The latter experiments with the docile-MI cells were performed with six times the number of aggressive-MI cells needed to kill irradiated recipients by adoptive transfer. The possible reasons for this discordance between CTL and in vivo killer function are discussed.     

长效和短效NO发生剂体内干预疟原虫红内期重要侵袭分子转录水平的观察

为探讨NO对疟原虫红内期侵袭相关分子MSP-1、AMA-1和RhopH complex转录水平的影响。通过雌性BALB／c小鼠腹腔感染1×10^6致死型约氏疟原虫P．yoelii 17XL,体内给予NO长效（NOC18）和短效（NOC5）发生剂进行干预后,纯化疟原虫成熟裂殖体,提取总RNA,通过Real—time PCR相对定量方法检测MSP-1、AMA—1和RhopH complex的转录水平。结果显示和正常感染组相比,NOC5处理后疟原虫侵入的关键分子MSP—1、AMA-1和RhopH complex的转录水平明显下降;而NOC18处理则未见这一现象。本研究结果提示NO抑制疟原虫侵袭关键分子的转录水平,进而可能下调疟原虫相应蛋白的表达,从而影响疟原虫的侵入过程。     

Leishmania infantum and Toxoplasma gondii: Mixed infection of macrophages in vitro and in vivo

Although macrophages have a microbicidal role in the immune system they themselves can be infected by pathogens. Often a simultaneous infection by more than one microbe may occur in a single cell. This is the first report of coinfection of macrophages with Toxoplasma gondii and Leishmania infantum, in vitro and in vivo. L. infantum does not cause severe disease in mice but T. gondii, RH strain, is lethal. Cell culture studies using THP-1 macrophages dually infected in vitro revealed that 4.3% harbored both parasites 24 h after infection. When mice were infected with both parasites on the same day 7.3% of the infected cells carried both parasites 7 days later. Yet, if mice were first infected with L. infantum and then with Toxoplasma (5 days post-infection) 18.7% of the macrophages hosted either parasite but concomitant infection could not be found and mice, already harboring L. infantum, survived Toxoplasma’s lethal effect.     

Stimulation of the cellular immune response to lymphocytic choriomeningitis (LCM) virus infection in suckling mice

Death occurred earlier and its rate was higher in one-week-old mice treated with phytohaemagglutinin (PHA) and subsequently inoculated intracerebrally with LCM virus than in their virus infected but untreated littermates. Thus PHA treatment contributed to the outcome of LCM virus infection in the form of lethal meningitis. The course of LCM virus infection in 1-week-old PHA treated mice was similar as in the untreated 2-week-old mice. This indicates that PHA treatment accelerated the development of cell mediated immunological capacity in suckling mice.     

The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice

Crimean-Congo hemorrhagic fever virus (CCHFV) is an important human pathogen. In cell culture, CCHFV is sensed by the cytoplasmic RNA sensor retinoic acid-inducible gene I (RIG-I) molecule and its adaptor molecule mitochondrial antiviral signaling (MAVS) protein. MAVS initiates both type I interferon (IFN-I) and proinflammatory responses. Here, we studied the role MAVS plays in CCHFV infection in mice in both the presence and absence of IFN-I activity. MAVS-deficient mice were not susceptible to CCHFV infection when IFN-I signaling was active and showed no signs of disease. When IFN-I signaling was blocked by antibody, MAVS-deficient mice lost significant weight, but were uniformly protected from lethal disease, whereas all control mice succumbed to infection. Cytokine activity in the infected MAVS-deficient mice was markedly blunted. Subsequent investigation revealed that CCHFV infected mice lacking TNF-α receptor signaling (TNFA-R-deficient), but not IL-6 or IL-1 activity, had more limited liver injury and were largely protected from lethal outcomes. Treatment of mice with an anti-TNF-α neutralizing antibody also conferred partial protection in a post-virus exposure setting. Additionally, we found that a disease causing, but non-lethal strain of CCHFV produced more blunted inflammatory cytokine responses compared to a lethal strain in mice. Our work reveals that MAVS activation and cytokine production both contribute to CCHFV pathogenesis, potentially identifying new therapeutic targets to treat this disease.